Echocardiography and anticoagulation treatment of patients with cardioembolic stroke
Authors:
J. Chlumský 1; M. Bojar 2
Authors place of work:
Univerzita Karlova v Praze
2. lékařská fakulta a Fakultní nemocnice Motol
; Interní klinika
Přednosta: prof. MUDr. Milan Kvapil, CSc., MBA.
1; Neurologická klinika
Přednosta: doc. MUDr. Martin Bojar, CSc.
2
Published in the journal:
Prakt. Lék. 2009; 89(9): 482-487
Category:
Reviews
Summary
Cardioembolism accounts for 20–25 % of ischemic strokes. Transthoracic echocardiography (TTE) can detect potential cardiac source of embolism in left atrium, on mitral or aortic valve (thrombi, myxoma, vegetation) or detect mitral valve disease. It is well recognized that rheumatic valvular heart disease is a risk factor for stroke. Left ventricular dysfunction, when severe, can lead to thromboembolism and stasis of blood flow within the heart. Transesophageal echocardiography (TEE) is more sensitive than TTE in the detection of potential cardiogenic sources of emboli. The sensitivity is nearly 100% in detecting left atrial thrombi, spontaneous echo contrast, atrial septal aneurysm, interatrial shunts supportive of a possible paradoxical cerebral embolus, ventricular thrombi or aneurysm. TEE is reported to reveal a left atrial appendage thrombus in roughly 10 % of patients with nonvalvular atrial fibrillation and in 20 to 40 % of patients with recent thromboembolism.
It is reported a significantly higher prevalence of patent foramen ovale in patients with ischemic stroke who were younger than 55 years of age. In detecting left atrial thrombi, spontaneous echo contrast, atrial septal aneurysm, interatrial shunts supportive of a possible paradoxical cerebral embolus, ventricular thrombi or aneurysm, or myxomatous mitral valve was 8 % when transthoracic echocardiography was performed and 46 % when transesophageal echocardiography was performed. The echocardiographic finding can decide in a fundamental way on the indication for anticoagulation treatment and thus reduce the risk of relapse of stroke.
Key words:
stroke, echocardiography, anticoagulation treatment.
Zdroje
1. Adams, H.P. Patent foramen ovale: paradoxical embolism and paradoxical data. Mayo Clin. Proc. 2004, 79, p. 15-20.
2. Abdelhafiz, A.H. A Review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation. Clin. Therap. 2001, 23, p. 1628-1636.
3. Aquilar, M.I., Hart, R.G., Pearce, L.A. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst. Rev. 2007, 3, CD006186.
4. Barnett, H.M. Stroke by cause. Some common, some exotic, some controversial. Stroke 2005, 36, p. 2523-2525.
5. Bath, P.M., Zhao, L., Heptinstall, S. Current status of stroke prevention in patients with atrial fibrillation. Eur. J. Cardiol. 2005, 7, Suppl, p. C12-C18.
6. Bell, C., Kapral, M. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. Canadian Task Force on Preventive Health Care. Can. J. Neurol. Sci. 2000, 27, p. 25-32.
7. Cauli, C., Barcellona, D., Marongiu, F. Oral anticoagulant therapy in the primary and secondary prophylaxis of stroke. Ital. Heart J. 2003, 4, p. 755-767.
8. Connolly, S., Pogue, J., Hart, R.G. et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006, 367, p. 1877-1878.
9. Corboy, J.R. Patent foramen ovale, atrial septal aneurysm, and recurrent stroke. N. Engl. J. Med. 2002, 346, p. 1331-1332.
10. Emmerich, J., Heuzey, L.J-Y., Bath, P.M.W., Connolly, S.J. Indication for antithrombotic therapy for atrial fibrillation: reconciling the guidelines with clinical practise. Eur. J. Cardiol. 2005, 7, Suppl, p. C28-C33.
11. Ferro, J.M. Cardioembolic stroke: an update. Lancet Neurology 2003, 2, p. 177-188.
12. Furberg, C.D. Natural statins and stroke risk. Circulation 1999, 99, p. 185-188.
13. Fuster, V., Ryden, L.E., Cannom, D.S. et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll. Cardiol. 2006, 48, p. 854-906.
14. Gage, B.F., van Walraven, C., Pearce, L. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004, 110, p. 2287-2292.
15. Go, A.S., Hylek, E.M., Chang, Y. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? JAMA 2003, 290, p. 2685-2692.
16. Gorelick, P.B., Sacco, R.L., Smith, D.B. et al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999, 281, p. 1112-1120.
17. Hardman, S.M.C., Cowie, M.R. Anticoagulation in heart disease. BMJ 1999, 318, p. 238-244.
18. Hart, R.G., Halperin, J.L. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann. Intern. Med. 1999, 131, p. 688-695.
19. Hart, R.G., Halperin, J.L., Pearce, L.A. Lessons from the stroke prevention in atrial fibrillation trials. Ann. Intern. Med. 2003, 138, p. 831-838.
20. Hart, R.G., Tonarelli, S.B., Pearce, L.A. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke 2005, 36, 1588-1593.
21. Hart, R.G., Pearce, L.A., Aguillar, M.I. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann. Intern. Med. 2007, 146, p. 857-867.
22. Heiro, M., Nikoskelainen, J., Engblom, E. Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch. Intern. Med. 2000, 160, p. 2781-2787.
23. Hirsh, J. Current anticoagulant therapy - unmet clinical needs. Thromb. Res. 2003, 109, S1-S8.
24. Homma, S., Di Tullio, M.R., Sacco, R.L. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke 1997, 28, p. 2376-2381.
25. Husain, A.M., Alter, M. Transesophageal echocardiography in diagnosing cardioembolic stroke. Clin. Cardiol. 1995, 18, p. 705-708.
26. Chaves, C.J., Caplan, L.R. Heparin and oral anticoagulants in the treatment of brain ischemia. J. Neurol. Sci. 2000, 173, p. 3-9.
27. Chlumský, J. Antikoagulační léčba. Praha: Grada, 2005, 235 s.
28. Chlumský, J., Charvát, J. Echocardiography and carotid sonography in diabetic patients after cerebrovascular attacks. J. Int. Med. Res. 2006, 34, p. 689-694.
29. Iqbal, M.B., Tajena, A.K., Lip, G.Y.H. et al. Recent developments in atrial fibrillation. BMJ 2005, 330, p. 238-243.
30. Jorgensen, H.S., Nakayama, H., Reith, J. et al. Acute stroke with atrial fibrillation. The Copenhagen Study. Stroke 1996, 27, p. 1765-1769.
31. Kapral, M.K., Silver, F.L. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ 1999, 161, p. 989-996.
32. Kronzon, I., Tunick, P.A. Transesophageal echocardiography as a tool in the evaluation of patients with embolic disorders. Progr. Cardiovasc. Dis. 1993, 36, p. 39-60.
33. Kronzon, I., Tunick, P.A. Aortic atherosclerotic disease and stroke. Circulation 2006, 114, p. 63-75.
34. Lin, H.J., Wolf, P.A., Kelly-Hayes, M. et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke 1996, 27, p. 1760-1764.
35. Mant, J., Hobbs, F.D.R., Fletcher, K. on behalf of the BAFTA investigators and the Midland Research Practices Network (MidReC), Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007, 370, p. 493-503.
36. Mattioli, A. V., Aquilina, M., Oldani, A. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur. Heart J. 2001, 22, p. 261- 268.
37. McNamara, R.L., Tamarou, L.J., Segal, J.B. et al. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann. Intern. Med. 2003, 139, p. 1018-1033.
38. Meissner, I., Whisnant, J.P., Khandheria, B.K. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention Assessment of Risk in a Community. Mayo Clin. Proc. 1999, 74, p. 862-869.
39. Messé, S.R., Silverman, I.E., Kizer, J.R. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004, 62, p. 1042-1050.
40. Rash, A., Downes, T., Portner, R. et al. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007, 36, p. 151-156.
41. Shermann, D.G. Stroke prevention in atrial fibrillation. Pharmacological rate versus rhythm control. Stroke 2007, 38, p. 615-617.
42. Son-Hing, M.M., Laupacis, A. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation. Arch. Intern. Med. 2002, 162, p. 541-550.
43. Strandberg, M., Marttila, R.J., Helenius, H., Hartiala, J. Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischemic attack. J. Neurol. Neurosurgery Psychiatry 2002, 73, p. 29-33.
44. Tan, C.N., Fraser, A.G. Transesophageal echocardiography and cardiovascular source of embolism. Anestesiology 2007, 107, p. 333-346.
45. Toman, J. Nitrosrdeční útvary a zdroje embolií. In Niederle P. Echokardiografie 1.díl. Praha: Triton 2003.
46. Uslu, N., Nurkalem, Z., Orhan, A.L. et al. Transthoracic echocardiographic predictors of the left atrial appendage contraction velocity in stroke patients with sinus rhythm. Tokohu J. Exp. Med. 2006, 20, p. 291-298.
47. Van Walraven, C., Hart, R.G., Singer, D.E. et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002, 288, p. 2441-2448.
Štítky
General practitioner for children and adolescents General practitioner for adultsČlánok vyšiel v časopise
General Practitioner
2009 Číslo 9
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Depression and anxiety in pregnant women
- Deliberate self-harm – a serious symptom and dangerous social phenomenon
- Dementia in a general practitioner‘s office
- Echocardiography and anticoagulation treatment of patients with cardioembolic stroke